Lumida
/AHCO
⌘K
Adapthealth Corp

Adapthealth Corp

AHCO
$6.19USD-4.62%-0.30 today

MARKET CAP

844.0M

P/E (TTM)

FWD P/E

DAY RANGE

$6 – $7

52W RANGE

$5
$13

AI Summary

Stalk
StalkMedium

AHCO remains in a bullish medium-term structure with successive higher highs and higher lows, supported by rising EMAs and strong up-day volume. Price is approaching resistance and is extended above key moving averages, suggesting patience is required. We will stalk for a pullback into the $10.50–$10.80 confluence zone for a higher-odds buy, as EMAs remain supportive and RSI holds above mid-range.

  • Aging US demographic drives rising demand for respiratory and home care services.
  • Trading at 52-week low $5.32 vs analyst targets of $9–$10.29 implies ~80% upside.
  • Revenue forecasts slashed from $3.45B to $2.87B; Q2 revenue $740M (-7.5% YoY).
Full analysis →

Buying

5

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY16.06 M167.37 M+122.04 K-11.8%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY764.34 K7.96 M+535.97 K+193.1%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL761.86 K7.94 M+-204.56 K-31.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY643.25 K6.70 M+412.85 K+144.5%0.00%
MM

Millennium Management LLC

Q2 2026

SELL347.92 K3.63 M+-313.30 K-53.9%0.00%
MG

Man Group Plc

Q2 2026

SELL290.03 K3.02 M+-124.46 K-38.7%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL131.15 K1.38 M+-43.57 K-30.1%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY76.60 K909.58 K+38.30 K+138.8%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY86.66 K903.03 K+26.28 K+25.7%0.01%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL74.97 K781.18 K+-80.18 K-57.7%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL467.004.87 K+-631.00-62.8%0.00%